LGCmain
Indian Journal of Pathology and Microbiology
Home About us Instructions Submission Subscribe Advertise Contact e-Alerts Ahead Of Print Login 
Users Online: 189
Print this page  Email this page Bookmark this page Small font sizeDefault font sizeIncrease font size
IJPM is coming out with a Special issue on "Genitourinary & Gynecological pathology including Breast". Please submit your articles for these issues

    Article Cited by others

ORIGINAL ARTICLE

Utility of p63 immunohistochemical stain in differentiating urothelial carcinomas from adenocarcinomas of prostate

Ud Din Nasir, Qureshi Asim, Mansoor Samina

Year : 2011| Volume: 54| Issue : 1 | Page no: 59-62

   This article has been cited by
 
1 Morphological and Immunohistochemical Biomarkers in Distinguishing Prostate Carcinoma and Urothelial Carcinoma: A Comprehensive Review
Francesca Sanguedolce,Davide Russo,Vito Mancini,Oscar Selvaggio,Beppe Calò,Giuseppe Carrieri,Luigi Cormio
International Journal of Surgical Pathology. 2019; 27(2): 120
[Pubmed]  [Google Scholar] [DOI]
2 NKX3.1 versus cyclin D1 expression in prostatic adenocarcinoma
Ihab S. Atta
Egyptian Journal of Pathology. 2017; 37(2): 306
[Pubmed]  [Google Scholar] [DOI]
3 HOXB13 protein expression in metastatic lesions is a promising marker for prostate origin
Justine Varinot,Adéline Furudoï,Sarah Drouin,Véronique Phe,Raphaele Renard Penna,Morgan Roupret,Marc-Olivier Bitker,Olivier Cussenot,Eva Compérat
Virchows Archiv. 2016; 468(5): 619
[Pubmed]  [Google Scholar] [DOI]
4 A diagnostic immunohistochemical panel for challenging cases of high-grade urothelial carcinoma versus high-grade prostatic adenocarcinoma
Nermine M. Abd Raboh,Somaia A. Saad,Hazem M. El-Hariri
Egyptian Journal of Pathology. 2016; 36(1): 29
[Pubmed]  [Google Scholar] [DOI]
5 Do HOXB13 and P63 have a role in differentiating poorly differentiated prostatic carcinoma from urothelial high-grade carcinoma?
Hanan AlSaeid Alshenawy,Eman Saied
APMIS. 2015; 123(9): 772
[Pubmed]  [Google Scholar] [DOI]
6 Immunohistochemical differential diagnosis between urothelial carcinoma and prostate adenocarcinoma among Egyptian patients
Saber A. Sakr,Moshera M. Abdel-Wahed,Doaa G. El-Sahra
Biomedicine & Pharmacotherapy. 2014; 68(6): 685
[Pubmed]  [Google Scholar] [DOI]
7 A novel subtype of primary prostatic adenocarcinoma: A case report
XIAOQING YANG,CHEN XU,JIANING GUO,CHUNRUI YANG,YUMING YANG,RUIFA HAN
Oncology Letters. 2013; 6(5): 1303
[Pubmed]  [Google Scholar] [DOI]
8 The expression of p63 in bladder cancer vs. chronic bilharzial bladder
Khaled Mursi,Ayman Agag,Olfat Hammam,Mahmoud Riad,Mahmoud Daw
Arab Journal of Urology. 2013; 11(1): 106
[Pubmed]  [Google Scholar] [DOI]
9 HOXB13 is a sensitive and specific marker of prostate cells, useful in distinguishing between carcinomas of prostatic and urothelial origin
Justine Varinot,Olivier Cussenot,Morgan Roupret,Pierre Conort,Marc-Olivier Bitker,Emmanuel Chartier-Kastler,Liang Cheng,Eva Compérat
Virchows Archiv. 2013;
[Pubmed]  [Google Scholar] [DOI]
10 Tissue-Preserving Antibody Cocktails to Differentiate Primary Squamous Cell Carcinoma, Adenocarcinoma, and Small Cell Carcinoma of Lung
Alan F. Brown,Deepika Sirohi,Junya Fukuoka,Philip T. Cagle,Maria Policarpio-Nicolas,David Tacha,Jaishree Jagirdar
Archives of Pathology & Laboratory Medicine. 2013; 137(9): 1274
[Pubmed]  [Google Scholar] [DOI]
11 Maturation of the developing human fetal prostate in a rodent xenograft model
Camelia M. Saffarini,Elizabeth V. McDonnell,Ali Amin,Daniel J. Spade,Susan M. Huse,Stefan Kostadinov,Susan J. Hall,Kim Boekelheide
The Prostate. 2013; 73(16): 1761
[Pubmed]  [Google Scholar] [DOI]
12 Urinzytologie – Update 2013
M. Böhm,F. Dorp,M. Schostak,O.W. Hakenberg
Der Urologe. 2013; 52(9): 1207
[Pubmed]  [Google Scholar] [DOI]

 

Read this article